NCT06867861 Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
| NCT ID | NCT06867861 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eastern Virginia Medical School |
| Condition | Gestational Diabetes Mellitus (GDM) |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2025-02-24 |
| Primary Completion | 2026-02-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2025-02-24 with a primary completion date of 2026-02-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.
Eligibility Criteria
Inclusion Criteria: * Singleton gestation * Known or new diagnosis of gestational diabetes without reason for medication * Age \>=18 to \<=50 Exclusion Criteria: * \- Non-English as primary language. * Known or suspected fetal anomaly or aneuploidy. * Known lower bowel disorder * Known phenylketonuria * Prisoners. * Management of diabetes outside of Eastern Virginia Medical School Maternal Fetal Medicine.
Contact & Investigator
Jerri Waller, MD
PRINCIPAL INVESTIGATOR
Macon & Joan Brock Virginia Health Sciences at Old Dominion University
Frequently Asked Questions
Who can join the NCT06867861 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Gestational Diabetes Mellitus (GDM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06867861 currently recruiting?
Yes, NCT06867861 is actively recruiting participants. Visit ClinicalTrials.gov or contact Eastern Virginia Medical School to inquire about joining.
Where is the NCT06867861 trial being conducted?
This trial is being conducted at Norfolk, United States.
Who is sponsoring the NCT06867861 clinical trial?
NCT06867861 is sponsored by Eastern Virginia Medical School. The principal investigator is Jerri Waller, MD at Macon & Joan Brock Virginia Health Sciences at Old Dominion University. The trial plans to enroll 110 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.